Furthermore, our study identified that the prevalence of tetraspanin+ EVs did not significantly differ between cancer patients and healthy individuals, and that the majority of CD9+ EVs, the most abundant subpopulation of tetraspanin+ EVs in body fluids, derive from non‐cancerous cells. Here, CD9 is linked to cancer.